Bortezomib therapy in myelofibrosis

A phase II clinical trial

R. A. Mesa, S. Verstovsek, Candido E Rivera, Animesh D Pardanani, K. Hussein, T. Lasho, W. Wu, Ayalew Tefferi

Research output: Contribution to journalArticle

16 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1636-1638
Number of pages3
JournalLeukemia
Volume22
Issue number8
DOIs
StatePublished - 2008

Fingerprint

Boronic Acids
Pyrazines
Phase II Clinical Trials
Primary Myelofibrosis
Antineoplastic Agents
Therapeutics
Bortezomib

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Bortezomib therapy in myelofibrosis : A phase II clinical trial. / Mesa, R. A.; Verstovsek, S.; Rivera, Candido E; Pardanani, Animesh D; Hussein, K.; Lasho, T.; Wu, W.; Tefferi, Ayalew.

In: Leukemia, Vol. 22, No. 8, 2008, p. 1636-1638.

Research output: Contribution to journalArticle

Mesa, R. A. ; Verstovsek, S. ; Rivera, Candido E ; Pardanani, Animesh D ; Hussein, K. ; Lasho, T. ; Wu, W. ; Tefferi, Ayalew. / Bortezomib therapy in myelofibrosis : A phase II clinical trial. In: Leukemia. 2008 ; Vol. 22, No. 8. pp. 1636-1638.
@article{4c4ab4fc7bb5461aba1bba7cf32e4d5b,
title = "Bortezomib therapy in myelofibrosis: A phase II clinical trial",
author = "Mesa, {R. A.} and S. Verstovsek and Rivera, {Candido E} and Pardanani, {Animesh D} and K. Hussein and T. Lasho and W. Wu and Ayalew Tefferi",
year = "2008",
doi = "10.1038/leu.2008.32",
language = "English (US)",
volume = "22",
pages = "1636--1638",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Bortezomib therapy in myelofibrosis

T2 - A phase II clinical trial

AU - Mesa, R. A.

AU - Verstovsek, S.

AU - Rivera, Candido E

AU - Pardanani, Animesh D

AU - Hussein, K.

AU - Lasho, T.

AU - Wu, W.

AU - Tefferi, Ayalew

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=49449108604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49449108604&partnerID=8YFLogxK

U2 - 10.1038/leu.2008.32

DO - 10.1038/leu.2008.32

M3 - Article

VL - 22

SP - 1636

EP - 1638

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 8

ER -